Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Pro, Barbara
Item TypeName
Concept Lymphoma
Concept Lymphoma, Follicular
Concept Lymphoma, Non-Hodgkin
Concept Lymphoma, B-Cell
Concept Lymphoma, T-Cell
Concept Lymphoma, Large B-Cell, Diffuse
Concept Lymphoma, T-Cell, Peripheral
Concept Lymphoma, AIDS-Related
Concept Lymphoma, Large-Cell, Anaplastic
Concept Lymphoma, B-Cell, Marginal Zone
Concept Lymphoma, Mantle-Cell
Concept Precursor Cell Lymphoblastic Leukemia-Lymphoma
Academic Article Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
Academic Article Marginal zone lymphomas: factors that affect the final outcome.
Academic Article Central nervous system prophylaxis in peripheral T-cell lymphoma.
Academic Article Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
Academic Article Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
Academic Article Hepatosplenic T-cell lymphoma and TNF-a inhibitors.
Academic Article Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
Academic Article Clinical roundtable monograph. Current management and treatment of T-cell lymphoma: A multidisciplinary approach.
Academic Article Hepatosplenic gamma-delta T-cell lymphoma, disseminated intravascular coagulation, and systemic mastocytosis: an unusual presentation for a rare disease.
Academic Article Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.
Academic Article Non-Hodgkin's lymphomas.
Academic Article Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Academic Article Hodgkin lymphoma.
Academic Article A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
Academic Article Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.
Academic Article Current treatment of peripheral T-cell lymphoma.
Academic Article Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Academic Article Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study.
Academic Article Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.
Academic Article Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.
Academic Article Second-Line 90Yttrium-Ibritumomab Tiuxetan (Zevalin) in a Patient With Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma Refractory to Rituximab.
Academic Article Brentuximab vedotin in Hodgkin's lymphoma.
Academic Article Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an f2-study database.
Academic Article Targeting CD30 in anaplastic large cell lymphoma.
Academic Article Non-Hodgkin's Lymphomas, version 3.2012.
Academic Article Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
Academic Article A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas.
Academic Article Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphoma.
Academic Article Non-Hodgkin's lymphomas, version 1.2013.
Academic Article Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.
Academic Article Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
Academic Article Peripheral T-cell lymphomas: a review of current approaches and hopes for the future.
Academic Article Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
Academic Article Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Academic Article Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Academic Article Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Academic Article International prognostic index-based outcomes for diffuse large B-cell lymphomas.
Academic Article Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Academic Article Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.
Academic Article Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Academic Article Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
Academic Article Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Academic Article Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
Academic Article Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Academic Article Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma.
Academic Article Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.
Academic Article Thalidomide for patients with recurrent lymphoma.
Academic Article Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation.
Academic Article New molecular targets for treatment of lymphoma.
Academic Article Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.
Academic Article Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.
Academic Article CD26/dipeptidyl peptidase IV and its role in cancer.
Academic Article Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Academic Article Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.
Academic Article Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.
Academic Article The lymphomas: molecular pathways and novel therapeutic targets.
Academic Article High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Academic Article Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma.
Academic Article Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma.
Academic Article Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Academic Article Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
Academic Article Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
Academic Article Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Academic Article Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
Academic Article Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
Academic Article Angioimmunoblastic T-cell lymphoma: still a dismal prognosis with current treatment approaches.
Academic Article Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
Academic Article Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics.
Academic Article Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
Academic Article Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy.
Academic Article Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma.
Academic Article The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
Academic Article Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
Academic Article Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Academic Article CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Academic Article Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
Academic Article Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Academic Article Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
Academic Article Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.
Academic Article Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
Academic Article Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Academic Article Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.
Academic Article Phase I Study of Panobinostat plus Everolimus in Patients with Relapsed or Refractory Lymphoma.
Academic Article Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting epstein-barr virus latent membrane proteins.
Academic Article Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).
Academic Article Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.
Academic Article The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study).
Academic Article Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30+ Peripheral T-Cell Lymphomas: Results of a Phase I Study.
Academic Article Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
Academic Article Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Academic Article (90) Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease.
Academic Article Kaposi sarcoma mimicking multiple cherry angiomata clinically and histologically in a patient with sezary syndrome: an unusual presentation.
Academic Article Recent advances in the treatment of T-cell lymphoma.
Academic Article Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial.
Academic Article Current management of peripheral T-cell lymphomas.
Academic Article Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.
Academic Article Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.
Academic Article Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Academic Article Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.
Academic Article Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Academic Article Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
Academic Article Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.
Academic Article A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Academic Article Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting.
Academic Article Brentuximab Vedotin in CD30+ Lymphomas.
Academic Article Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
Academic Article A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
Academic Article Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial.
Academic Article Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.
Academic Article Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials.
Academic Article Report of the 6th International Workshop on PET in lymphoma.
Academic Article Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Academic Article Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Academic Article Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
Academic Article Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm.
Academic Article Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor alpha therapy.
Academic Article Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Academic Article Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.
Academic Article Five-Year Outcomes for Frontline Brentuximab Vedotin with CHP for CD30 Expressing Peripheral T-Cell Lymphomas.
Academic Article NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
Academic Article Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
Academic Article Hemophagocytic Lymphohistiocytosis in Cutaneous T-Cell Lymphoma.
Academic Article Transforming growth factor superfamily ligands and links to tumorigenesis.
Academic Article Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Academic Article The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Academic Article Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Academic Article Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Academic Article Single Agents Versus Combination Chemotherapy in Relapsed and Refractory Peripheral T-cell Lymphoma: Results from the Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment (COMPLETE) Registry.
Academic Article Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
Academic Article Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
Academic Article Progression of Cutaneous T-Cell Lymphoma after dupilumab: Case review of 7 patients.
Academic Article Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.
Academic Article Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes.
Academic Article NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
Academic Article Diagnosis, Risk Stratification, and Treatment of Peripheral T-Cell Lymphomas: Past and Present.
Academic Article Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study.
Academic Article Hepatosplenic T-cell lymphoma: A rare but challenging entity.
Academic Article Venetoclax-rituximab ± bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma: CONTRALTO.
Academic Article NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
Academic Article Pembrolizumab followed by AVD in untreated early unfavorable and advanced stage classical Hodgkin lymphoma.
Academic Article Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma.
Academic Article Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Academic Article Management of ALCL and other CD30+ peripheral T-cell lymphomas with a focus on Brentuximab vedotin.
Academic Article A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV?+?lymphomas.
Academic Article Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.
Search Criteria
  • Lymphoma